Qi, Nienie <br/><br/>
Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.  [electronic resource] 

 -  World journal of surgical oncology  Jan 2017 
 - 4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1477-7819 
<br/><br/><label>Standard No.: </label>10.1186/s12957-016-1066-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Renal Cell--mortality<br/>Combined Modality Therapy<br/>Cytoreduction Surgical Procedures--mortality<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kidney Neoplasms--mortality<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--mortality<br/>Neoplasm Staging<br/>Nephrectomy--mortality<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Thrombectomy--mortality<br/>Thrombosis--mortality<br/>Vena Cava, Inferior--pathology<br/>Young Adult